Multidetector-row computed tomography in the management of hepatocellular carcinoma with transcatheter arterial chemoembolization

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 6, 2006, Pages 941-946

  Guan, Yong Song ^a   Hu, Ying ^a   Liu, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Multidetector row computed tomography; Transcatheter arterial chemoembolization

Indexed keywords

IODINATED POPPYSEED OIL;

CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EVALUATION; HUMAN; LIVER CELL CARCINOMA; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; VASCULARIZATION;

EID: 33744761204     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04474.x     Document Type: Review

References (52)

1. Qin LX Tang ZY. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J. Gastroenterol. 2002 8:193 9.
2. Ueno K Miyazono N Inoue H Nishida H Kanetsuki I Nakajo M. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000 88:1574 81.
3. Kamada K Nakanishi T Kitamoto M et al. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. J. Vasc. Interv. Radiol. 2001 12:847 54.
4. Zhang Z Liu Q He J Yang J Yang G Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000 89:2606 12.
5. Chen MS Li JQ Zhang YQ et al. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J. Gastroenterol. 2002 8:74 8.
6. Huppert PE Lauchart W Duda SH et al. Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival? Rofo 2004 176:375 85.
7. Sandstede JJ Tschammler A Beer M Vogelsang C Wittenberg G Hahn D. Optimization of automatic bolus tracking for timing of the arterial phase of helical liver CT. Eur. Radiol. 2001 11:1396 400.
8. Bader TR Prokesch RW Grabenwoger F. Timing of the hepatic arterial phase during contrast-enhanced computed tomography of the liver: assessment of normal values in 25 volunteers. Invest. Radiol. 2000 35:486 92.
9. Foley WD Mallisee TA Hohenwalter MD Wilson CR Quiroz FA Taylor AJ. Multiphase hepatic CT with a multirow detector CT scanner. AJR 2000 175:679 85.
10. Murakami T Kim T Takamura M et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 2001 218:763 7.
11. Mitsuzaki K Yamashita Y Ogata I Nishiharu T Urata J Takahashi M. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. AJR 1996 167:753 7.
12. Oliver JH III. Baron RL Federle MP Rockette HE Jr.. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR 1996 167:71 7.
13. Oliver JH III. Baron RL Federle MP Jones BC Sheng R. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection? Radiology 1997 205:709 15.
14. Baron RL Oliver JH III. Dodd GD III., Nalesnik M Holbert BL Carr B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 1996 199:505 11.
15. Paulson EK McDermott VG Keogan MT DeLong DM Frederick MG Nelson RC. Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 1998 206:143 50.
16. Guan YS Zheng XH Zhou XP et al. Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. World J. Gastroenterol. 2004 10:2127 9.
17. Cheng HY Shou Y Wang X Xu AM Chen D Jia YC. Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT. World J. Gastroenterol. 2004 10:2753 5.
18. Sanada Y Shiozaki S Aoki H Takakura N Yoshida K Yamaguchi Y. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma: assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol. Res. 2005 32:185 95.
19. Lo CM Ngan H Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002 35:1164 71.
20. Puhalla H Schuell B Pokorny H Kornek GV Scheithauer W Gruenberger T. Treatment and outcome of intrahepatic cholangiocellular carcinoma. Am. J. Surg. 2005 189:173 7.
21. Cherqui D Tantawi B Alon R et al. Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch. Surg. 1995 130:1073 8.
22. Chu KM Lai EC Al-Hadeedi S et al. Intrahepatic cholangiocarcinoma. World J. Surg. 1997 21:301 5.
23. Casavilla FA Marsh JW Iwatsuki S et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J. Am. Coll. Surg. 1997 185:429 36.
24. Ando E Tanaka M Yamashita F et al. Chemotherapy for hepatocellular carcinoma with portal hypertension due to tumor thrombus. J. Clin. Gastroenterol. 2000 31:247 9.
25. Sagawa N Kondo S Morikawa T Okushiba S Katoh H. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg. Today 2005 35:548 52.
26. Gerhards MF van Gulik TM Gonzalez Gonzalez D Rauws EA Gouma DJ. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J. Surg. 2003 27:173 9.
27. Jin CB Wu F Wang ZB Chen WZ Zhu H. High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi 2003 25:401 3.
28. Burger I Hong K Schulick R et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J. Vasc. Interv. Radiol. 2005 16:353 61.
29. Kong J Dou YC Xu LF Liang HM Wu HP Feng GS. The related to the fibrotic indicators of primary hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Chin. J. Hepatobiliary Surg. 2002 8:414 16.
30. Zhu KS Shan H Huang MS et al. The content changes of serum liver fibrosis indicators after transcatheterial chemoembolization for primary hepatic carcinoma and their clinical significance. Lin Chuan Fang She Xue Za Zhi 2000 19:208 10.
31. Lu W Li YH Li ZG Chen Y He XF Zhao JB. A comparative study on necrosis and hepatocellular carcinoma cells after TACE with use of low dose and conventional-dose anticancer drugs. Chin. J. Radiol. 2003 37:232 7.
32. Farinati F De Maria N Marafin C et al. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig. Dis. Sci. 1996 41:2332 9.
33. Lu W Li YH He XF Chen Y. A comparative study of serum fibrosis indications after TACE with use of low dose versus conventional-dose anticancer drugs in hepatocellular carcinoma. J. Interv. Radiol. 2004 13:247 9.
34. Lu W Li YH He X Chen Y. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors. Hepatogastroenterology 2003 50:2079 83.
35. Kwok PC Lam TW Lam PW et al. Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2003 18:450 5.
36. Cheng HY Xu AM Chen D Jia YC. Study of lipiodol dose for TACE of large hepatocellular carcinoma according to the blood supply of tumors with multidetector helical CT. Jie Ru Fang She Xue Za Zhi 2003 12:357 61.
37. Nakao N Uchida H Kamino K et al. Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. Cardiovasc. Intervent. Radiol. 1994 17:76 80.
38. Matsuo N Uchida H Sakaguchi H et al. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Semin. Oncol. 1997 24 Suppl. 6 S6 61-S6-70.
39. Vogl TJ Trapp M Schroeder H et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success: results from a liver transplantation center. Radiology 2000 214:349 57.
40. Zhang G Zhou XP Guan YS. A study of the relationship between the blood supplies and iodized oil deposition in primary liver cancer after TACE. J. Med. Imaging 2004 14:718 21.
41. Chung YH. A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Intervirology 2005 48:46 51.
42. Arnold MM Kreel L Wallace AC Li AK. Distribution of Lipiodol and evidence for tumor necrosis in hepatocellular carcinoma. Am. J. Clin. Pathol. 1992 97:405 10.
43. Takayasu K Arii S Matsuo N et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR 2000 175:699 704.
44. Choi BI Kim HC Han JK et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 1992 182:709 13.
45. Fukukura Y Nakashima O Kusaba A Kage M Kojiro M. Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J. Hepatol. 1998 29:470 5.
46. Gaiani S Piscaglia F Serra C Bolondi L. Hemodynamics in focal nodular hyperplasia. J. Hepatol. 1999 31:576.
47. Hussain SM Terkivatan T Zondervan PE et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004 24:3 17.
48. Shortell CK Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg. Gynecol. Obstet. 1991 173:426 31.
49. Terkivatan T de Wilt JHW de Man RA et al. Indications and outcome of treatment for benign hepatic tumors: a critical appraisal. Arch. Surg. 2001 136:1033 8.
50. Chung KY Mayo-Smith WW Saini S Rahmouni A Golli M Mathieu D. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR 1995 165:303 8.
51. Horton KM Bluemke DA Hruban RH Soyer P Fishman EK. CT and MR imaging of benign hepatic and biliary tumors. Radiographics 1999 19:431 51.
52. Choi BI. Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis. J. Korean Med. Sci. 1998 13:103 16.